{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:06Z","timestamp":1789609086352,"version":"build-2803163510"},"reference-count":24,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,8,9]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>The kidney is one of the major organs affected in preeclampsia. There is evidence suggesting a role for excessive complement activation in the pathogenesis of preeclampsia. We describe a case of preeclampsia with severe features, including HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) and acute kidney injury (AKI) that developed following caesarian section. The patient required renal replacement therapy. A trial of daily plasma exchange was not effective. The patient received a single dose of eculizumab, a humanised monoclonal IgG antibody that binds to complement protein C5. One week post administration of eculizumab, there was significant improvement in haematologic, hepatic and renal function. Blood pressure had normalised and renal replacement therapy was discontinued. The use of eculizumab may have contributed to recovery of kidney function further supporting the role of complement activation in the pathogenesis of preeclampsia and associated AKI.<\/jats:p>","DOI":"10.1136\/bcr-2018-228709","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T05:05:33Z","timestamp":1567746333000},"page":"e228709","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":32,"title":["Eculizumab, a novel potential treatment for acute kidney injury associated with preeclampsia\/HELLP syndrome"],"prefix":"10.1136","volume":"12","author":[{"given":"Hatem","family":"Elabd","sequence":"first","affiliation":[{"name":"Internal Medicine Department, Albert Einstein College of Medicine\/Jacobi Medical Center, Bronx, New York, USA"},{"name":"Internal Medicine Department, Cairo University, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mennallah","family":"Elkholi","sequence":"additional","affiliation":[{"name":"Department of Obstetric and Gynecology, Alexandria University, Alexandria, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Steinberg","sequence":"additional","affiliation":[{"name":"Medicine Department, Hematology & Oncology Division, Albert Einstein College of Medicine\/Jacobi Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Acharya","sequence":"additional","affiliation":[{"name":"Medicine Department, Nephrology Division, Albert Einstein College of Medicine\/Jacobi Medical Center, Bronx, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,9,5]]},"reference":[{"key":"2025082802334224000_12.9.e228709.1","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12000"},{"key":"2025082802334224000_12.9.e228709.2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-2388"},{"key":"2025082802334224000_12.9.e228709.3","unstructured":"ACOG. Executive Summary: Hypertension in Pregnancy: American Obstetrics and Gynecology, 2013."},{"key":"2025082802334224000_12.9.e228709.4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(86)90266-8"},{"key":"2025082802334224000_12.9.e228709.5","doi-asserted-by":"publisher","DOI":"10.1053\/plac.2002.0903"},{"key":"2025082802334224000_12.9.e228709.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2011.12.006"},{"key":"2025082802334224000_12.9.e228709.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa031884"},{"key":"2025082802334224000_12.9.e228709.8","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.194324"},{"key":"2025082802334224000_12.9.e228709.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2010.01.021"},{"key":"2025082802334224000_12.9.e228709.10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.2012.01158.x"},{"key":"2025082802334224000_12.9.e228709.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001013"},{"key":"2025082802334224000_12.9.e228709.12","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.exphem.2016.01.005","article-title":"Direct evidence of complement activation in HELLP syndrome: A link to\u00a0atypical hemolytic uremic syndrome","volume":"44","author":"Vaught","year":"2016","journal-title":"Exp Hematol"},{"key":"2025082802334224000_12.9.e228709.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00316.x"},{"key":"2025082802334224000_12.9.e228709.14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200317189"},{"key":"2025082802334224000_12.9.e228709.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707330"},{"key":"2025082802334224000_12.9.e228709.16","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2003.44.1.75"},{"key":"2025082802334224000_12.9.e228709.17","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05484"},{"key":"2025082802334224000_12.9.e228709.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08099.x"},{"key":"2025082802334224000_12.9.e228709.19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40620-018-0517-z","article-title":"Eculizumab in pregnancy: a narrative overview","volume":"32","author":"Sarno","year":"2019","journal-title":"J Nephrol"},{"key":"2025082802334224000_12.9.e228709.20","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31828e2612"},{"key":"2025082802334224000_12.9.e228709.21","first-page":"1421","article-title":"Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome","volume":"93","author":"Ca\u00f1igral","year":"2014","journal-title":"Ann Hematol"},{"key":"2025082802334224000_12.9.e228709.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2012.11.014"},{"key":"2025082802334224000_12.9.e228709.23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/1753495X17704563","article-title":"Pregnancy-induced atypical haemolytic uremic syndrome: a new era with eculizumab","volume":"11","author":"Shanmugalingam","year":"2018","journal-title":"Obstetric Medicine"},{"key":"2025082802334224000_12.9.e228709.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-03-144691"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-228709","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:33:51Z","timestamp":1756373631000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-228709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,5]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/bcr-2018-228709"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-228709","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}